Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Drug Delivery market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

27 Item(s)

Page 1 of 3

  1. Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period

    By: CBR Pharma Insights
    , Published: Nov-2016
    , Product code: GBI072CBR
    GBI Research’s latest report, "Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period" discusses the drug delivery technologies and trends in the market and the evolving business strategies being adopted and leveraged by companies globally. The ultimate goal of drug delivery research is to develop formulations and devices that can be used in clinical applications to treat various diseases. Delivering a drug with the desired release kinetics requires an understanding of the underlying physicochemical properties of the drug, which determine the type of delivery material and drug release mechanism. Numerous parameters need to be considered, and their inter-dependence has to be taken into account to develop successful drug delivery systems for the intended applications. It is important to understand the complexity associated with the development of a drug delivery system that can ultimately be used in human patients. The report covers the currently available drug delivery technologies and recent advances in the field, with granular analyses of the different types of delivery systems, their advantages, disadvantages and opportunities for future development. The report provides global market forecasts by revenue for the market until 2020. Additionally, forecasts by revenue for key geographical markets and supporting analyses of the main factors driving or restraining growth are included. The market for drug delivery technology is poised for strong growth in the coming years. Key factors promoting growth include the rapidly expanding injectables market, the growing incidence of chronic diseases and the expected significant increase in the use of complex biologic drugs that necessitate novel delivery systems. Drug delivery companies have had to adapt to challenging times in the same way as pharmaceutical companies have had to over the past decade. These companies have achieved this by adopting new business strategies that allow them to take better control of their commercial and financial future. The report analyzes how business models in this dynamic industry have evolved over the last couple of decades and how new companies with improved product portfolios and propositions are emerging.
    $2,995.00

  2. Spine Implants Market in the US 2016-2020

    By: Technavio
    , Published: Oct-2016
    , Product code: IRTNTR10636
    The report covers the present scenario and the growth prospects of the spine implants market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales generated from the sales of spine implants.
    $2,500.00

  3. Global Chronic Lymphocytic Leukemia market 2016-2020

    By: Technavio
    , Published: Jun-2016
    , Product code: IRTNTR9378
    The report covers the present scenario and the growth prospects of the global CLL therapeutics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent CLL. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.
    $2,500.00

  4. Global Hyperphosphatemia Drugs Market Insights, Opportunities, Analysis, Market Shares and Forecast 2016 – 2022

    By: Occams Research
    , Published: May-2016
    , Product code: HPH-1611015
    Hypophosphatemia predicted in patients who have an antiquity of starvation, anorexia/bulimia, alcoholism. Adequate cure comprises phosphate supplements along with feeding and care to causal eating disorders or substance exploitation. The global hypophosphatemia drugs market is driven by increasing aging population. According to WHO the world aged population by the end of 2050 is expected to reach 2 billion that is 900 million in 2015. Now Around 125 million people aged 80 years or more. By the end of 2050 almost 125 million people aged 80 years or more is expected to reach in China alone and 434 million people across the globe. Approximately 80% people live in low and middle income countries by the end of 2050. As the increasing aging population is one of the major driving factor of global hypophosphatemia drugs market.
    $3,900.00

  5. Global Intrathecal Pumps Market 2016-2020

    By: Technavio
    , Published: May-2016
    , Product code: IRTNTR9288
    The report covers the present scenario and the growth prospects of the global intrathecal pumps market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the sales of intrathecal pumps.
    $2,500.00

  6. Global Bio-Implant Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022

    By: Occams Research
    , Published: Apr-2016
    , Product code: HME-1411015
    The global bio-implants market is driven by various factors which include global rise in adoption of bio-implants, increase in number of people suffering from disabilities. It is giving rise to higher number of amputation. Rising incidence and prevalence rate of CVD, CHD and other heart diseases is also driving the market growth. Additionally, with increasing adoption of prosthetic limbs across geographies and rise in awareness about ear implants, pacemakers and other bio-implants are creating huge scope for global bio-implant market.
    $3,900.00

  7. Global Biosimulation Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022

    By: Occams Research
    , Published: Apr-2016
    , Product code: HAD-1261015
    Biosimulation is explained as a computer-aided mathematical simulation of biological processes and systems and hence is an integral part of systems biology. The main aim of Biosimulation is model-based prediction of the behavior and the dynamics of biological systems e.g. the response of an organ or a single cell towards a chemical. It is a predictive tool and used in discovery stage to determine the future outcomes of current experimental trials.
    $3,900.00

  8. Global Metabolomics Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022

    By: Occams Research
    , Published: Apr-2016
    , Product code: HME-1591015
    Metabolomics can be defined as the study of metabolites or low molecular weight molecules found inside the cells and the biological systems. This branch of science basically aims at the comparison finding out the differences between biological samples and is based on their metabolite profile. Metabolomics generally makes the use of analytical process like Chromatography, spectroscopy and multi variable analysis.
    $3,900.00

  9. Global Injectable Drug Delivery Partnering 2010-2016 - Apr2016.pdf

    By: Current Partnering
    , Published: Apr-2016
    , Product code: CP2102inj
    Global Injectable Drug Delivery Partnering 2010-2016 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies
    $1,995.00

  10. Global Topical Drug Delivery Partnering 2010-2016 - Apr2016.pdf

    By: Current Partnering
    , Published: Apr-2016
    , Product code: CP2102top
    Global Topical Drug Delivery Partnering 2010-2016 provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies
    $1,995.00

27 Item(s)

Page 1 of 3